Table 3.
H-FABP levels in relation to cardiovascular events in patients with pre-DM and DM
IGM | HRs (95% CIs) | |||
---|---|---|---|---|
Unadjusted | p value | Adjusteda | p value | |
Pre-DM | ||||
Tertile 1 | Reference | – | Reference | – |
Tertile 2 | 1.206 (0.762–1.908) | 0.424 | 0.971 (0.556–1.234) | 0.728 |
Tertile 3 | 1.864 (1.203–2.890) | 0.005 | 1.335 (1.059–1.772) | 0.039 |
DM | ||||
Tertile 1 | Reference | – | Reference | – |
Tertile 2 | 1.142 (0.820–1.608) | 0.628 | 1.012 (0.795–1.423) | 0.772 |
Tertile 3 | 1.631 (1.161–2.362) | 0.021 | 1.322 (1.035–1.730) | 0.040 |
Italic values indicate statistical significance
Pre-DM pre-diabetes mellitus, DM diabetes mellitus, H-FABP heart-type fatty acid-binding protein, HRs hazard ratios, CIs confidential intervals
aAdjusted for age, gender, hypertension, dyslipidemia, body mass index, current smoking, family history of CAD and Gensini score, eGFR